Tigermed Consulting kicks off Hong Kong secondary listing

Jonathan Breen

July 20, 2020 08:15 am

Shenzhen-listed Hangzhou Tigermed Consulting has caught the attention of international and local investors for its secondary listing on the Hong Kong exchange, set to be worth at least $1bn.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC Securities Equity IPOs Equity China Bank of America China International Capital Corp Hong Kong SAR Asia Greater China Haitong Securities Northeast Asia Asia Pacific Emerging Markets

JB

Jonathan Breen

Equities editor GlobalCapital Asia